Girindus signed a commercial collaboration agreement with RiboTask, a small-scale provider of oligonucleotides for use in R&D. RiboTask will gain access to Girindus’ worldwide sales and marketing team and Girindus will have the ability to offer its customers seamless manufacture of a wide variety of oligonucleotides from the mg quantity to commercial kg quantities. “Prof. Jesper Wengel, chairman of the board of RiboTask, has long been recognized as one of the leaders in the oligonuc...